How can we help?
Neuro-protective and Neuro-degenerative
- Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures
- Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
- Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
- Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
- Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury
- CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
- CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
- Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity
- Endocannabinoid Signaling In Neurotoxicity And Neuroprotection
- Endocannabinoids and traumatic brain injury
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
- Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling
- Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity
- Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
- Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
- Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity
- Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
- Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
- Prospects for cannabinoid therapies in basal ganglia disorders
- Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death
- Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
- The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia–Ischemia
- The cannabinoids: An overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
- The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K Akt mTORC1 BDNF pathway
- The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
- The endocannabinoid system as a target for the treatment of neurodegenerative disease
- The endocannabinoid system in normal and pathological brain ageing
- Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity